Dermatology Experts Present Latest Information at AAD VMX 2021

Dermatology experts at the AAD VMX 2021, a virtual meeting experience taking place April 23-25, will feature the latest information on skin, hair, and nails, presented by world-renowned experts in the field of dermatology.

Board-Certified Dermatologist Warns Consumers About the Dangers of Skin Bleaching to Achieve a Lighter Complexion

Despite the potential dangers of skin bleaching products, the global market for skin lighteners last year was estimated at $8.6 billion. With the market projected to reach $12.3 billion by 2027, a board-certified dermatologist from the American Academy of Dermatology expresses concern about this growing trend and the unintended health consequences of pursuing lighter skin at any cost. Read more.

Board-Certified Dermatologist Shares How Visible Light Impacts the Skin

Visible light is all around us. From nature’s sunlight to artificial light sources from ceiling lights, our phones, computer screens and TVs, we may be exposed to more visible light than ever before, but what does that mean for our skin? Read more.

New Research Focuses on a Growing Pandemic Problem – “Zoom Dysmorphia”

During the pandemic, there was a shift to remote work, and demand for video conferencing increased. A board-certified dermatologist shares findings revealing how increased exposure on camera, combined with the distorting effects of front-facing cameras, is leading patients to think negatively about their appearance and seek cosmetic care — a new phenomenon she calls “Zoom Dysmorphia.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”